Hi-D Imaging
Hi-D Imaging is a Swiss-based company founded in 2019 that develops AI-powered software and digital twin services to revolutionize pre-operational planning for cardiovascular diseases, particularly structural heart interventions like transcatheter aortic valve replacement (TAVR). Their flagship product, the Cardiovascular Imaging Suite with the FDA-cleared 4TAVR software, automates the processing of CT heart scans to provide fast, accurate, and reproducible anatomical measurements and 3D visualizations, reducing manual work and variability in clinical decision-making. The company combines expertise in fluid dynamics, machine learning, computer vision, 3D printing, and in vitro imaging to create patient-specific digital twins that optimize medical device development and treatment planning. Hi-D Imaging collaborates with leading medical institutions and has validated its technology in multiple clinical studies across Switzerland, Europe, and the USA, positioning itself as a global leader in cardiac image analysis and cardiovascular treatment planning innovation.
Hi-D Imaging
Hi-D Imaging is a Swiss-based company founded in 2019 that develops AI-powered software and digital twin services to revolutionize pre-operational planning for cardiovascular diseases, particularly structural heart interventions like transcatheter aortic valve replacement (TAVR). Their flagship product, the Cardiovascular Imaging Suite with the FDA-cleared 4TAVR software, automates the processing of CT heart scans to provide fast, accurate, and reproducible anatomical measurements and 3D visualizations, reducing manual work and variability in clinical decision-making. The company combines expertise in fluid dynamics, machine learning, computer vision, 3D printing, and in vitro imaging to create patient-specific digital twins that optimize medical device development and treatment planning. Hi-D Imaging collaborates with leading medical institutions and has validated its technology in multiple clinical studies across Switzerland, Europe, and the USA, positioning itself as a global leader in cardiac image analysis and cardiovascular treatment planning innovation.
TL;DR
Founded: 2019
Headquarters: Winterthur, Switzerland
Flagship product: 4TAVR (FDA 510(k) cleared)
Focus: AI-based pre-operative planning and digital twins for cardiovascular interventions
Employees (approx.): 10
Company Overview
Problem Domain
Pre-operative planning and image analysis for cardiovascular disease, especially structural heart interventions such as TAVR.
Founded
2019
Industry
Medical imaging / Healthcare software
Funding Track Record
Most recent disclosed funding round was a grant on 2022-07-01